SARS, pneumothorax, and our response to epidemics.
Filice
Gregory A
GA
D000900:Anti-Bacterial Agents; D002170:Canada / Q000453:epidemiology; D002423:Cause of Death; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006723:Hong Kong / Q000453:epidemiology; D006801:Humans; D008297:Male; D011030:Pneumothorax / Q000175:diagnosis / Q000453:epidemiology*; D011031:Pneumothorax, Artificial / Q000009:adverse effects* / Q000401:mortality; D018570:Risk Assessment; D045473:Severe acute respiratory syndrome-related coronavirus / Q000302:isolation & purification*; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents